AUG 18, 2026 · JOURNAL ARTICLE
High-dose inhaled nitric oxide for severe pneumonia caused by multidrug-resistant bacteria: a randomized controlled trial protocol.
Annals of Medicine
This is a published protocol for a prospective randomized controlled trial not yet completed; it describes planned methods and outcomes but reports no results, making it a hypothesis-generating document rather than evidence of efficacy.
Reported
Sample size (planned)98
Allocation ratio1:1
Intervention dose200 ppm